Why APO-go® Pen? | APO-GO | Britannia Pharmaceuticals
The use of Apomorphine in Parkinson's disease:
Parkinson's Drug Apomorphine set to enter Eastern India
How Do I Take APOKYN®? - APOKYN® (apomorphine HCI) for PD
Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians | Neurodegenerative Disease Management
Apo Pen, Apo Pump offer new lease of life for Parkinson's patients in India
W Communication Agency - MORE ON-TIME WITH APO-GO® APO-go PEN CAMPAIGN When Grünenthal launched APO-go pen, a treatment of Parkinson's disease, they needed urgent help – a complete product launch package adapted
Apomorphine | Parkinson's UK
Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians | Neurodegenerative Disease Management
Apomorphine | Parkinson's UK
SciELO - Brasil - Apomorphine in the treatment of Parkinson's disease: a review Apomorphine in the treatment of Parkinson's disease: a review
Why APO-go® Pen? | APO-GO | Britannia Pharmaceuticals
APO-GO 10 mg/ml X 5 SOL. INJ. IN PEN MULTIDOZA 10mg/ml STADA ARZNEIMITTEL A - Pret 848,38 Lei
APOKYN® for Parkinson's Disease Off Episodes
Summary of Product Characteristics
Summary of Product Characteristics
Apomorphine | Parkinson's UK
Apomorphine for Use in Parkinson's Disease
DCGI nod for device-aided therapy for Parkinson's patients | Hyderabad News - Times of India
Dr Vinodh Metta | Vijaya Group Hospitals launches APO PEN and APO PUMP for Parkinsons Disease - YouTube
APO-go Pen 10mg/ml Solution for Injection - Summary of Product Characteristics (SmPC) - (emc)
APPLICATION FOR A NON-FORMULARY DRUG
APO-GO PEN 10MG/ML - Name Patient Medical Supply Pharmaceutical Export
Apomorphine information sheet (PDF, 185KB) - Parkinson's UK
